PRESS RELEASE Leading generics maker is usually recognized for excellent growth.

FDA or in development cover a broad selection of therapeutic categories. Furthermore to high-volume commodity medicines, Amneal’s portfolio contains many high-barrier-to-access and difficult-to-formulate products and spans almost the entire selection of dosage forms on the market. To produce the highest quality generic medications for its customers and accelerate its incredible growth, Amneal is producing major investments in research and development, infrastructure, and human being capital.The 10-year study, published in Pediatrics, discovered simply three % of kids’ emergency visits led to a codeine prescription in 2010 2010, but with more than 25 million er visits by children each year, the authors say far too many kids are receiving the drug when better options can be found. The study’s lead author, Dr. Sunitha Kaiser, a co-employee pediatrics professor at the University of California, SAN FRANCISCO BAY AREA, says doctors and parents should know about codeine’s drawbacks and that alternatives are available, including dark honey for coughs in children over age group 1; and ibuprofen or the opiate drug hydrocodone, for discomfort including broken bones. Dr. Dyan Hes, medical director at Gramercy Pediatrics in New York, said on CBS TODAY that she was floored by the analysis.